Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Vulvovaginal Candidiasis Treatment Market would witness market growth of 5.3% CAGR during the forecast period (2022-2028).

The rising awareness regarding VVC in developing nations, as well as the rise in patient inclination towards maintaining genital health, is further raising the demand for vulvovaginal candidiasis treatment. A large proportion of women across the globe have a weak immune system which raises the risk of vulvovaginal candidiasis. Therefore, various market players are increasing investment in research & development activities and clinical trials of drugs.

Getting yeast infections is very common among pregnant women. This happens due to increased estrogen in the body of pregnant women, which may lead to throwing off the normal balance of bacteria and yeast in the vagina, thereby resulting in yeast overgrowth. Most yeast infections during pregnancy often result from the fungus candida Albicans.

The treatment of vulvovaginal candidiasis majorly focuses on suppositories and intravaginal cream. Nowadays, oral fluconazole is majorly used for the treatment of acute vulvovaginal candidiasis. Also, gynecologists prefer pre-intravaginal preparations due to their limited systematic absorption and possible minimal side effects.

Regional nations such as India are among the largest providers of generic drugs. India is a major producer as well as consumer in the pharmaceutical sector. India is among the major exporters of pharmaceutics across more than 200 nations. The rising focus of the government of several regional nations on menstrual hygiene, as well as awareness regarding women's health, is further supporting the expansion of the femtech industry in the Asia region. Considering all these elements, the market for vulvovaginal candidiasis treatment would expand in the region during the projection period.

The China market dominated the Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country in 2021; thereby, achieving a market value of $101.5 million by 2028. The Japan market is registering a CAGR of 4.7% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 5.9% during (2022 - 2028).

Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Route of Administration, the market is segmented into Oral, Intravenous and Topical. Based on Drug Class, the market is segmented into Fluconazole, Clotrimazole, Terconazole, Terbinafine, Nystatin, Ketoconazole and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Vulvovaginal Candidiasis Treatment Market is Projected to reach USD 1.3 Billion by 2028, at a CAGR of 4.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Bristol Myers Squibb Company, Pfizer, Inc., Astellas Pharma, Inc., Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC), Basilea Pharmaceutica Ltd., Scynexis, Inc. and Grupo Ferrer Internacional S.A.

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Route of Administration

• Oral
• Intravenous
• Topical

By Drug Class

• Fluconazole
• Clotrimazole
• Terconazole
• Terbinafine
• Nystatin
• Ketoconazole
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG
• Bristol Myers Squibb Company
• Pfizer, Inc.
• Astellas Pharma, Inc.
• Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC)
• Basilea Pharmaceutica Ltd.
• Scynexis, Inc.
• Grupo Ferrer Internacional S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Vulvovaginal Candidiasis Treatment Market, by Distribution Channel
1.4.2 Asia Pacific Vulvovaginal Candidiasis Treatment Market, by Route of Administration
1.4.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market, by Drug Class
1.4.4 Asia Pacific Vulvovaginal Candidiasis Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
3.1 Asia Pacific Retail Pharmacy Market by Country
3.2 Asia Pacific Hospital Pharmacy Market by Country
3.3 Asia Pacific Online Pharmacy Market by Country

Chapter 4. Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Intravenous Market by Country
4.3 Asia Pacific Topical Market by Country

Chapter 5. Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
5.1 Asia Pacific Fluconazole Market by Country
5.2 Asia Pacific Clotrimazole Market by Country
5.3 Asia Pacific Terconazole Market by Country
5.4 Asia Pacific Terbinafine Market by Country
5.5 Asia Pacific Nystatin Market by Country
5.6 Asia Pacific Ketoconazole Market by Country
5.7 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country
6.1 China Vulvovaginal Candidiasis Treatment Market
6.1.1 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.2 China Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.3 China Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2 Japan Vulvovaginal Candidiasis Treatment Market
6.2.1 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.2 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.3 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3 India Vulvovaginal Candidiasis Treatment Market
6.3.1 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.2 India Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.3 India Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4 South Korea Vulvovaginal Candidiasis Treatment Market
6.4.1 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.2 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.3 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class
6.5 Singapore Vulvovaginal Candidiasis Treatment Market
6.5.1 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.5.2 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.5.3 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class
6.6 Malaysia Vulvovaginal Candidiasis Treatment Market
6.6.1 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.6.2 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.6.3 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class
6.7 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market
6.7.1 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.7.2 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.7.3 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class

Chapter 7. Company Profiles
7.1 Bayer AG
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.3 Bristol Myers Squibb Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Astellas Pharma, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management, LLC)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.6 Basilea Pharmaceutica Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Scynexis, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expenses
7.7.4 Recent strategies and developments:
7.7.4.1 Trials and Approvals:
7.8 Grupo Ferrer Internacional S.A.
7.8.1 Company Overview

TABLE 1 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Fluconazole Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Fluconazole Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Clotrimazole Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Clotrimazole Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Terconazole Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Terconazole Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Terbinafine Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Terbinafine Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Nystatin Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Nystatin Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Ketoconazole Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Ketoconazole Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 37 China Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 38 China Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 39 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 40 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 41 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 44 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 45 Japan Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 46 Japan Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 47 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 52 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 53 India Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 54 India Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 55 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 56 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 57 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 60 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 61 South Korea Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 62 South Korea Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 63 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 64 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 65 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 68 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 69 Singapore Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 70 Singapore Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 71 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 76 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 77 Malaysia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 78 Malaysia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 79 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 80 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 81 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 84 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 91 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 92 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 93 Key Information – Bayer AG
TABLE 94 Key Information – Pfizer, Inc.
TABLE 95 Key Information – Bristol Myers Squibb Company
TABLE 96 key information – Astellas Pharma, Inc.
TABLE 97 Key Information – Mycovia Pharmaceuticals, Inc.
TABLE 98 Key Information – Basilea Pharmaceutica Ltd.
TABLE 99 Key Information – Scynexis, Inc.
TABLE 100 Key Information – Grupo Ferrer Internacional S.A.

List of Figures
FIG 1 Methodology for the research